141 related articles for article (PubMed ID: 9608825)
1. The hypoxaemia in chronic obstructive pulmonary disease (COPD) and its management.
Voisin C
Wiad Lek; 1998; 51(1-2):11-4. PubMed ID: 9608825
[TBL] [Abstract][Full Text] [Related]
2. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE
Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987
[TBL] [Abstract][Full Text] [Related]
3. Adherence to entry criteria and one year experience of long-term oxygen therapy in Poland.
Górecka D; Sliwiński P; Zieliński J
Eur Respir J; 1992 Jul; 5(7):848-52. PubMed ID: 1499709
[TBL] [Abstract][Full Text] [Related]
4. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
5. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
[TBL] [Abstract][Full Text] [Related]
6. Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
Daskalopoulou E; Patakas D; Tsara V; Kazis A; Maniki E; Zoglopitis F
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():185s-190s. PubMed ID: 3690030
[TBL] [Abstract][Full Text] [Related]
7. [Effect of home oxygen therapy on patients with chronic obstructive lung diseases].
Sliwiński P
Pneumonol Alergol Pol; 1992; 60(9-10):20-7. PubMed ID: 1292826
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy of sleep-related hypoxaemia.
Weitzenblum E; Apprill M; Oswald M; Kurtz D
Lung; 1990; 168 Suppl():948-54. PubMed ID: 2143553
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
Sans-Torres J; Domingo C; Morón A; Rué M; Marín A
Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
[TBL] [Abstract][Full Text] [Related]
10. [Predictors of survival in patients with chronic obstructive pulmonary disease with moderate hypoxemia].
Gorzelak K; Sliwiński P; Tobiasz M; Górecka D; Zieliński J
Pol Arch Med Wewn; 1995 Jun; 93(6):491-7. PubMed ID: 7491349
[TBL] [Abstract][Full Text] [Related]
11. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.
Górecka D; Gorzelak K; Sliwiński P; Tobiasz M; Zieliński J
Thorax; 1997 Aug; 52(8):674-9. PubMed ID: 9337824
[TBL] [Abstract][Full Text] [Related]
13. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
Nowak D; Wywiol A; Magnussen H
Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
[TBL] [Abstract][Full Text] [Related]
14. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy.
Dubois P; Machiels J; Smeets F; Delwiche JP; Lulling J
Eur Respir J; 1990 Oct; 3(9):1042-7. PubMed ID: 2289552
[TBL] [Abstract][Full Text] [Related]
15. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
Pinet C; Tessonnier F; Ravel T; Orehek J
Respir Med; 2001 Jul; 95(7):602-5. PubMed ID: 11453318
[TBL] [Abstract][Full Text] [Related]
16. [Critical study of the indications for long-term oxygen therapy. Chronic obstructive bronchopneumopathies].
Sadoul P; Duwoos H; Pretet S
Rev Mal Respir; 1988; 5(4):363-72. PubMed ID: 3140316
[TBL] [Abstract][Full Text] [Related]
17. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
18. [The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention].
Xu FP; Cai YY; Niu SF
Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):479-81, 511. PubMed ID: 2128259
[TBL] [Abstract][Full Text] [Related]
19. [Sleep and COPD].
Weitzenblum E; Chaouat A; Charpentier C; Krieger J
Rev Prat; 1995 May; 45(10):1257-60. PubMed ID: 7659971
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
